Young et al. [26] recently used a neonatal mouse model of pulmonary hypertension and found that the inhibition of CXCR4 activity significantly decreased hypoxia-induced pulmonary hypertension. This evidence concerns the gene CXCR4 and pulmonary arterial hypertension.